FDA Will Inspect Firms That Didn’t Participate In U.S.-Canada Program
This article was originally published in The Gray Sheet
Executive Summary
Manufacturers that turned down FDA's offer to participate in its Pilot Multipurpose Audit Program (PMAP) will soon be inspected by the agency, CDRH's compliance chief says
You may also be interested in...
Good Deal? Firms Seek Details On FDA ISO Audit Report Submission Program
Device makers generally support FDA's plan for accepting voluntary international audit reports as a means for possibly delaying an FDA inspection, but firms say more details need to be spelled out before many will agree to participate
Good Deal? Firms Seek Details On FDA ISO Audit Report Submission Program
Device makers generally support FDA's plan for accepting voluntary international audit reports as a means for possibly delaying an FDA inspection, but firms say more details need to be spelled out before many will agree to participate
GMP Inspection Results Can No Longer Stay Within Borders, Says FDA
Results from manufacturing facility inspections conducted in one country will easily be shared with regulators in another in the near term, says Larry Kessler, FDA officer and chair of the Global Harmonization Task Force